OXYBUTYNIN CL ER 5 MG TABLET

What it is

OXYBUTYNIN CL ER 5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “oxybutynin chloride” and “oxybutynin”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Oxybutynin Chloride Extended Release”.

FDA gives its dosage form as “tablet, extended release” and “tablet, film coated, extended release” and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Accord Healthcare, Inc. and Ajanta Pharma USA Inc.

FDA’s Established Pharmacologic Class for it is Cholinergic Muscarinic Antagonist.

The NADAC file of 2026-10-14 prices it under 22 NDCs (National Drug Codes); the FDA directory lists 19 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.52 for 30 tablets (30 × $0.08414 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

The 11 labelers

Other strengths, forms and brands

8 other products in the NADAC file share an FDA nonproprietary name with OXYBUTYNIN CL ER 5 MG TABLET.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 22 NDCs’ NADAC prices is $0.08414 per EA filed.

Of the 25 other products in FDA’s Cholinergic Muscarinic Antagonist class priced per EA, 24 have a higher middle NADAC price and 1 a lower one. The one in the middle is TOLTERODINE TART ER 2 MG CAP, at $0.2678 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $10.77 for 30 tablets, at an average of $0.35898 per EA in 2024 (2024-01-01 to 2024-12-31) for “Oxybutynin Chloride ER” and “Oxybutynin Chloride”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,420,475 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

19 of the product’s 22 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.